Investment
Features
FeesSafety
Academy
More
Pluang+

NANO Nuclear advances NRC review of KRONOS MMR™ permit, aiming to start construction in late 2027

Market News
13 Oct 2026
Newsfile Corp
View Source
Bullish
NANO Nuclear advances NRC review of KRONOS MMR™ permit, aiming to start construction in late 2027

NANO Nuclear Energy and the University of Illinois are progressing through the U.S. Nuclear Regulatory Commission's review of their KRONOS MMR™ microreactor Construction Permit Application. The NRC's detailed audit and technical review are ongoing, with key milestones including draft environmental and safety assessments expected by early to mid-2027. This progress supports NANO Nuclear's goal to begin initial construction activities in the second half of 2027, pending regulatory approvals. The project represents a significant step toward demonstrating advanced nuclear microreactor technology for clean energy and research applications.

NANO Nuclear's KRONOS MMR™ program progress is noted with Pluang's Energy sector market data as of Oct 13, 2026 18:41 WIB. For readers following Energy-sector US stocks, here is Pluang's market snapshot: of 62 priced stocks, 40 rose and 19 fell today. Notable movers include TotalEnergies SE (TTE) at USD 89.04 with a 0.76% increase and a typical hold time of 91 days, Solaredge Technologies Inc (SEDG) at USD 31.25 with a 0.73% decrease and a 97% buy order activity, and Williams Companies Inc (WMB) at USD 74.70 with a 0.71% increase. The most notable figure is the 97% buy order activity for SEDG.

More News

Schrödinger stock dips 5% amid $55M Tectora co-founding and upcoming earnings forecast.

Schrödinger stock dips 5% amid $55M Tectora co-founding and upcoming earnings forecast.

Schrödinger's stock fell 5.02% to $25.91 despite co-founding Tectora, a new biopharma venture with $55 million funding targeting immune and inflammatory treatments. The company, known for its molecular modeling software, holds a market value of about...

Analyst Insights
Bullish
42 minutes ago
Johnson & Johnson beats Q3 earnings estimates, driven by strong pharmaceutical growth.

Johnson & Johnson beats Q3 earnings estimates, driven by strong pharmaceutical growth.

Johnson & Johnson reported third-quarter 2026 earnings per share of $2.59, surpassing analyst estimates of $2.52, with total revenue of $25.40 billion slightly above expectations. The company saw robust growth in its pharmaceutical segment, which off...

Company Fundamentals
Bullish
50 minutes ago
TSMC Q3 revenue beats forecasts as AI chip demand fuels strong growth.

TSMC Q3 revenue beats forecasts as AI chip demand fuels strong growth.

TSMC's preliminary Q3 2026 revenue reached approximately NT$1.49 trillion, about 50% higher year-over-year and above management guidance, driven by strong AI chip demand. The company holds a dominant 73% share of the global pure-play foundry market, ...

Company Fundamentals
Bullish
56 minutes ago
Inc. and SurveyMonkey launch Growth Signals to capture insights from fast-growing businesses.

Inc. and SurveyMonkey launch Growth Signals to capture insights from fast-growing businesses.

Inc. and SurveyMonkey have launched Growth Signals, a new initiative to regularly poll entrepreneurs and business leaders of fast-growing companies. This program aims to capture their priorities, challenges, and growth outlook to inform Inc.'s editor...

Others
Neutral
56 minutes ago
BNB Standard launches new website with real-time treasury dashboard to boost transparency and educate investors.

BNB Standard launches new website with real-time treasury dashboard to boost transparency and educate investors.

BNB Standard Corporation has launched a new corporate website featuring an expanded treasury dashboard that updates its Adjusted Net Asset Value and other key financial metrics intraday. This move aims to increase transparency and accountability in t...

Market News
Bullish
56 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App